Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections - PubMed (original) (raw)
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections
S E Hawes et al. J Infect Dis. 1996 Nov.
Abstract
This cohort study of 182 women attending a sexually transmitted disease clinic evaluated the hypothesis that women colonized by lactobacilli have decreased acquisition of vaginal infections. During a 2-year follow-up, 50 women acquired bacterial vaginosis (BV), 25 acquired symptomatic vulvovaginal candidiasis (VVC), and 7 acquired vaginal trichomoniasis. By multivariate analysis, utilizing Cox proportional hazards modeling with time-dependent covariates, acquisition of BV was independently associated with lack of vaginal H2O2-producing lactobacilli (hazard ratio [HR] = 4.0, P < .001) or presence of only non-H2O2-producing lactobacilli (HR = 2.2, P = .02). Acquisition of BV was associated with having a new sex partner (HR = 2.5, P = .004) and with douching for hygiene (HR = 2.1, P = .05). Absence of lactobacilli did not increase acquisition of VVC. Trichomoniasis was associated only with having a new sex partner (HR = 4.7, P = .05). These results support the hypothesis that H2O2-producing vaginal lactobacilli protect against acquisition of BV but do not protect against VVC or vaginal trichomoniasis.
Similar articles
- Hydrogen peroxide producing lactobacilli in women with vaginal infections.
Mijac VD, Dukić SV, Opavski NZ, Dukić MK, Ranin LT. Mijac VD, et al. Eur J Obstet Gynecol Reprod Biol. 2006 Nov;129(1):69-76. doi: 10.1016/j.ejogrb.2005.11.036. Epub 2006 Jul 11. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16814920 - Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis.
Mitchell C, Fredricks D, Agnew K, Hitti J. Mitchell C, et al. Sex Transm Dis. 2015 Jul;42(7):358-63. doi: 10.1097/OLQ.0000000000000298. Sex Transm Dis. 2015. PMID: 26222747 Free PMC article. - Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, Mandaliya K, Kiarie J, Jaoko W, Ndinya-Achola JO, Baeten JM, Kurth AE, Holmes KK. McClelland RS, et al. J Infect Dis. 2008 May 15;197(10):1361-8. doi: 10.1086/587490. J Infect Dis. 2008. PMID: 18444793 Free PMC article. Clinical Trial. - The role of lactobacilli and probiotics in maintaining vaginal health.
Borges S, Silva J, Teixeira P. Borges S, et al. Arch Gynecol Obstet. 2014 Mar;289(3):479-89. doi: 10.1007/s00404-013-3064-9. Epub 2013 Oct 30. Arch Gynecol Obstet. 2014. PMID: 24170161 Review. - Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME, Betsi GI, Athanasiou S. Falagas ME, et al. J Antimicrob Chemother. 2006 Aug;58(2):266-72. doi: 10.1093/jac/dkl246. Epub 2006 Jun 21. J Antimicrob Chemother. 2006. PMID: 16790461 Review.
Cited by
- Under conditions closely mimicking vaginal fluid, Lactobacillus jensenii strain 62B produces a bacteriocin-like inhibitory substance that targets and eliminates Gardnerella species.
Navarro S, Abla H, Colmer-Hamood JA, Ventolini G, Hamood AN. Navarro S, et al. Microbiology (Reading). 2023 Nov;169(11):001409. doi: 10.1099/mic.0.001409. Microbiology (Reading). 2023. PMID: 37909284 Free PMC article. - Influence of connatural factors in shaping vaginal microflora and ensuring its health.
Das S, Konwar BK. Das S, et al. Arch Gynecol Obstet. 2024 Mar;309(3):871-886. doi: 10.1007/s00404-023-07200-8. Epub 2023 Sep 7. Arch Gynecol Obstet. 2024. PMID: 37676318 Review. - An Overview of the Microbiota of the Human Urinary Tract in Health and Disease: Current Issues and Perspectives.
Colella M, Topi S, Palmirotta R, D'Agostino D, Charitos IA, Lovero R, Santacroce L. Colella M, et al. Life (Basel). 2023 Jun 30;13(7):1486. doi: 10.3390/life13071486. Life (Basel). 2023. PMID: 37511861 Free PMC article. Review. - Rapid-dissolving electrospun nanofibers for intra-vaginal antibiotic or probiotic delivery.
Minooei F, Gilbert NM, Zhang L, Sarah NeCamp M, Mahmoud MY, Kyser AJ, Tyo KM, Watson WH, Patwardhan R, Lewis WG, Frieboes HB, Lewis AL, Steinbach-Rankins JM. Minooei F, et al. Eur J Pharm Biopharm. 2023 Sep;190:81-93. doi: 10.1016/j.ejpb.2023.07.009. Epub 2023 Jul 19. Eur J Pharm Biopharm. 2023. PMID: 37479065 Free PMC article. - Inhibition of Toxic Shock Syndrome-Associated Staphylococcus aureus by Probiotic Lactobacilli.
Schlievert PM, Gaitán AV, Kilgore SH, Roe AL, Maukonen J, Lehtoranta L, Leung DYM, Marsman DS. Schlievert PM, et al. Microbiol Spectr. 2023 Aug 17;11(4):e0173523. doi: 10.1128/spectrum.01735-23. Epub 2023 Jul 5. Microbiol Spectr. 2023. PMID: 37404182 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical